THE PROGENICS BOARD HAS THE EXPERIENCE NECESSARY TO SUCCESSFULLY OVERSEE THE CONTINUED COMMERCIALIZATION OF AZEDRA AND THE COMPANY’S PIPELINE OF OTHER RADIOPHARMACEUTICALS
We strongly believe the Progenics Board has the right mix of skills and experience to effectively guide the Company to long-term success.
Format
PNG
Source
Progenics Pharmaceuticals Inc.